Profil
Michal Segal-Salto is currently the Chief Human Resources Officer & Senior VP at Delta Galil Industries Ltd. and also holds the position of Vice President-Human Resources at IDE Technologies Ltd. Previously, Michal worked as the Vice President-Research & Development at Chemomab Therapeutics Ltd. from 2015 to 2022.
Michal has a doctorate degree from the Weizmann Institute of Science and completed undergraduate and graduate studies at The Hebrew University of Jerusalem.
Aktive Positionen von Michal Segal-Salto
| Unternehmen | Position | Beginn |
|---|---|---|
| DELTA GALIL INDUSTRIES LTD. | Personalreferent | 01.01.2023 |
IDE Technologies Ltd.
IDE Technologies Ltd. Industrial MachineryProducer Manufacturing Designs, manufactures and installs water desalination equipment | Personalreferent | - |
Ehemalige bekannte Positionen von Michal Segal-Salto
| Unternehmen | Position | Ende |
|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Technik-/Wissenschafts-/F&E-Leiter | 12.08.2022 |
Ausbildung von Michal Segal-Salto
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Delta Galil Industries Ltd.
Delta Galil Industries Ltd. Apparel/FootwearConsumer Non-Durables Manufactures and markets undergarments and intimate apparel | Consumer Non-Durables |
IDE Technologies Ltd.
IDE Technologies Ltd. Industrial MachineryProducer Manufacturing Designs, manufactures and installs water desalination equipment | Producer Manufacturing |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotech company | Health Technology |
















